PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » LabCorp’s Stocks Slightly Drops Over Q2 Earnings Report Anticipation

Photo: UC San Diego Jacobs School of Engineering | Flickr | CC BY 2.0

Photo: UC San Diego Jacobs School of Engineering | Flickr | CC BY 2.0

LabCorp’s Stocks Slightly Drops Over Q2 Earnings Report Anticipation

by PublicWire
June 26, 2019
in Medical
Reading Time: 2 mins read
0

LabCorp (NYSE: LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 27, 2019, and amid anticipation over its quarterly numbers, the company’s stocks are at a loss following a data breach affecting its partner billing, AMCA.

LabCorp closed Tuesday with a 0.73% decline from its already resilient stocks. While after-hours trading has seen a slight increase, controversies, and legal action against the company still affects its market performance. The company slightly went up by 0.27% on its after-hours trading.

LabCorp has been in the center of controversy following the announcement of a massive data breach involving American Medical Collection Agency, LabCorp’s billing partner whose portal has been hacked compromising financial data of more than 20 million Americans.

Last week, when the breach was fresh, shares of LabCorp have climbed 7.5% against the industry ‘s 4.1% decline over the last three months. Furthermore, the company reported strong underlying performance and organic revenue growth across both Diagnostics and Drug Development businesses, banking on solid execution of three fundamental strategies, which are delivering advanced diagnostics, bringing new medicines to patients faster and using technology to improve the patient care in the first quarter of 2019.

But the company’s future is still unclear for analysts. More than 11 class-suite actions have been filed against LabCorp and its partners for their inability to protect consumer data. The 11 lawsuits were recorded at The United States Judicial Panel on Multidistrict Litigation (JPML) on June 3. Since then, eight more lawsuits were filed against the companies in federal courts from New Jersey, New York, and California.

According to litigation experts, “If many cases are filed in federal court, any of the lawyers on any of those cases can file a motion with the JPML [..] to centralize the various federal cases that have been filed by sending all of them to a single judge for coordinated pre-trial proceedings.”

Previous Post

Libra Might Have Motivated Bitcoin’s Price Blasts

Next Post

Bitcoin Continues To Rally; Reaches $13,000+

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Medical

FDA advisory panel recommends Moderna, Johnson & Johnson vaccine booster shots

October 18, 2021
0
Medical

Walgreens invests $5.5B to accelerate new healthcare business segment

October 18, 2021
0
Medical

Mayo Clinic to study respiratory muscle training as long COVID treatment

October 18, 2021
0
Medical

Anthem, Providence tap Vim for value-based care platform deployment

October 25, 2021
0
Medical

Healthcare lost 17,500 jobs in September amid ongoing labor shortage

October 25, 2021
0
Medical

Cigna divests life, accident and supplemental benefits businesses for $5.75B

October 25, 2021
0
Next Post
Photo: Hektor Ehring Jeppesen | Flickr | CC BY 2.0

Bitcoin Continues To Rally; Reaches $13,000+

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.